| 000 | 01302 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515141235.0 | ||
| 264 | 0 | _c20090420 | |
| 008 | 200904s 0 0 ger d | ||
| 022 | _a0340-2592 | ||
| 024 | 7 |
_a10.1007/s00120-008-1797-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBecker, A J | |
| 245 | 0 | 0 |
_a[The basics of phosphodiesterase type 5 (PDE5) inhibition in urology]. _h[electronic resource] |
| 260 |
_bDer Urologe. Ausg. A _cDec 2008 |
||
| 300 |
_a1582-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErectile Dysfunction _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhosphodiesterase 5 Inhibitors |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSexual Dysfunction, Physiological _xdrug therapy |
| 700 | 1 | _aUckert, S | |
| 700 | 1 | _aStief, C G | |
| 773 | 0 |
_tDer Urologe. Ausg. A _gvol. 47 _gno. 12 _gp. 1582-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00120-008-1797-z _zAvailable from publisher's website |
| 999 |
_c18319668 _d18319668 |
||